These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3050182)

  • 1. [Current antimicrobial agent series II: Ticarcillin].
    Ueda Y
    Jpn J Antibiot; 1988 Jul; 41(7):761-81. PubMed ID: 3050182
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combinations of beta-lactamase inhibitors and semisynthetic penicillins: amoxycillin/clavulanic acid (augmentin, amox-clav ), thycarcillin/clavulanic acid (thymentin). Action and usage].
    Fomina IP
    Antibiot Khimioter; 1997; 42(12):29-32. PubMed ID: 9480651
    [No Abstract]   [Full Text] [Related]  

  • 3. [New antimicrobial agent series XXXVII: potassium clavulanate/Ticarcillin sodium].
    Fujimori I
    Jpn J Antibiot; 1991 Apr; 44(4):365-87. PubMed ID: 1880918
    [No Abstract]   [Full Text] [Related]  

  • 4. Relevant breakpoints for ticarcillin-clavulanic acid should be set primarily with data from ticarcillin-resistant strains.
    Sanders CC; Cavalieri SJ
    J Clin Microbiol; 1990 Apr; 28(4):830-1. PubMed ID: 2332481
    [No Abstract]   [Full Text] [Related]  

  • 5. Ticarcillin-clavulanate therapy for infections with ticarcillin-resistant microorganisms.
    Gelfand MS; Lawson RD; Baucom W
    South Med J; 1989 Apr; 82(4):433-7. PubMed ID: 2705069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timentin versus piperacillin in the treatment of hospitalized patients with urinary tract infections.
    Cox CE
    J Antimicrob Chemother; 1986 May; 17 Suppl C():93-6. PubMed ID: 3636340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of Timentin in complicated urinary tract infections.
    Westenfelder M; Pelz K; Hulla FW
    J Antimicrob Chemother; 1986 May; 17 Suppl C():97-102. PubMed ID: 3636341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative activity in vitro of ticarcillin and ticarcillin plus clavulanic acid against Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter calcoaceticus.
    Campos P; Vera A; Martin-Luengo F
    Chemioterapia; 1987 Jun; 6(2 Suppl):77-8. PubMed ID: 3151358
    [No Abstract]   [Full Text] [Related]  

  • 9. [Activity of ticarcillin combined with different concentrations of clavulanic acid on 137 Gram-negative bacilli resistant to ticarcillin].
    Aubert G; Dorche G; Frere A; Raby N; Denis M
    Pathol Biol (Paris); 1987 May; 35(5):537-41. PubMed ID: 3302858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility testing recommendations for ticarcillin/clavulanic acid in the Stokes' disc diffusion test.
    Sutherland R
    J Antimicrob Chemother; 1989 Sep; 24(3):463-4. PubMed ID: 2808198
    [No Abstract]   [Full Text] [Related]  

  • 11. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
    Nomura S; Hanaki H; Nagayama A
    J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of clinical bacterial isolates to Timentin (ticarcillin/clavulanic acid).
    Villiger JW
    N Z Med J; 1986 Nov; 99(814):914. PubMed ID: 3492692
    [No Abstract]   [Full Text] [Related]  

  • 13. Ticarcillin-clavulanic acid therapy in severe infections.
    Van der Auwera P; Legrand JC
    Drugs Exp Clin Res; 1985; 11(11):805-13. PubMed ID: 3836862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemical structure, anti-bacterial activity and pharmacokinetics of penicillins].
    Miyashita T; Ono Y; Kunii O
    Nihon Rinsho; 1991 Oct; 49(10):2266-70. PubMed ID: 1660944
    [No Abstract]   [Full Text] [Related]  

  • 15. Ticarcillin and clavulanic acid in serious infections.
    Kosmidis J
    J Antimicrob Chemother; 1986 May; 17 Suppl C():169-75. PubMed ID: 3636332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro activity of the combination ticarcillin-clavulanic acid on bacterial isolates in surgery].
    Branger C; Kitzis M; Le Mée J
    Pathol Biol (Paris); 1986 Apr; 34(4):245-8. PubMed ID: 3528998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of timentin in intensive care].
    Gérard A; Dureux JB; Canton P; May T; Schmit JL
    Pathol Biol (Paris); 1986 May; 34(5):448-50. PubMed ID: 3534719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of beta-lactamase inhibitors.
    Sutherland R
    J Reprod Med; 1990 Mar; 35(3 Suppl):307-12. PubMed ID: 2319512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of varying ratios of ticarcillin to clavulanic acid against gentamicin-resistant and gentamicin-sensitive Enterobacteriaceae.
    Wheat PF; Spencer RC
    J Antimicrob Chemother; 1984 Aug; 14(2):195-6. PubMed ID: 6568225
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of a ticarcillin-clavulanic acid (timentin) combination on bacteria resistant to ticarcillin].
    Rouhan D; Le Noc P; Robert J
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):461-5. PubMed ID: 3937121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.